Is SunLink Health Stock a Good Investment?

SunLink Health Investment Advice

  SSY
To provide specific investment advice or recommendations on SunLink Health Systems stock, we recommend investors consider the following general factors when evaluating SunLink Health Systems. This will help you to make an informed decision on whether to include SunLink Health in one of your diversified portfolios:
  • Examine SunLink Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research SunLink Health's leadership team and their track record. Good management can help SunLink Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact SunLink Health's business and its evolving consumer preferences.
  • Compare SunLink Health's performance and market position to its competitors. Analyze how SunLink Health is positioned in terms of product offerings, innovation, and market share.
  • Check if SunLink Health pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about SunLink Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in SunLink Health Systems stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if SunLink Health Systems is a good investment.
 
Sell
 
Buy
Strong Sell
We provide advice to complement the current expert consensus on SunLink Health. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure SunLink Health Systems is not overpriced, please validate all SunLink Health fundamentals, including its cash and equivalents, cash flow from operations, and the relationship between the gross profit and debt to equity . As SunLink Health Systems appears to be a penny stock we also recommend to double-check its number of shares shorted numbers.

Market Performance

Very WeakDetails

Volatility

Abnormally volatileDetails

Hype Condition

StaleDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Not AvailableDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails

Examine SunLink Health Stock

Researching SunLink Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. SunLink Health Systems recorded a loss per share of 0.33. The entity last dividend was issued on the 29th of September 1989. The firm had 105:100 split on the 22nd of November 1993.
To determine if SunLink Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding SunLink Health's research are outlined below:
SunLink Health has some characteristics of a very speculative penny stock
SunLink Health had very high historical volatility over the last 90 days
The company reported the last year's revenue of 32.44 M. Reported Net Loss for the year was (1.53 M) with profit before taxes, overhead, and interest of 4.71 M.
SunLink Health Systems has about 4.49 M in cash with (2.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.97, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
SunLink Health has a frail financial position based on the latest SEC disclosures
Roughly 27.0% of the company outstanding shares are owned by corporate insiders
Latest headline from MacroaxisInsider: Disposition of 28219 shares by Howard Turner of SunLink Health subject to Rule 16b-3
SunLink Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in SunLink Health Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to SunLink Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

SunLink Health's market capitalization trends

The company currently falls under 'Nano-Cap' category with a total capitalization of 6.05 M.

Market Cap

7.43 Million

SunLink Health's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.08) 0.01 
Return On Capital Employed(0.15)(0.04)
Return On Assets(0.07) 0.01 
Return On Equity(0.10) 0.05 
The company has Net Profit Margin of (0.02) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.15) %, which entails that for every $100 of revenue, it lost $0.15.
Determining SunLink Health's profitability involves analyzing its financial statements and using various financial metrics to determine if SunLink Health is a good buy. For example, gross profit margin measures SunLink Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of SunLink Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in SunLink Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SunLink Health Systems. Check SunLink Health's Beneish M Score to see the likelihood of SunLink Health's management manipulating its earnings.

Evaluate SunLink Health's management efficiency

SunLink Health Systems has Return on Asset of (0.0954) % which means that on every $100 spent on assets, it lost $0.0954. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1476) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, SunLink Health's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.01 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.04). At this time, SunLink Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 24.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.7 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 2.27  2.01 
Tangible Book Value Per Share 2.10  1.71 
Enterprise Value Over EBITDA 2.23 (176.45)
Price Book Value Ratio 0.35  0.74 
Enterprise Value Multiple 2.23 (176.45)
Price Fair Value 0.35  0.74 
Enterprise Value3.1 M2.9 M
Leadership at SunLink Health emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Beta
1.397

Basic technical analysis of SunLink Stock

As of the 25th of November, SunLink Health has the Risk Adjusted Performance of 0.0079, variance of 15.4, and Coefficient Of Variation of (436,521). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of SunLink Health Systems, as well as the relationship between them.

SunLink Health's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific SunLink Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on SunLink Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases SunLink Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Howard Turner over two weeks ago
Disposition of 28219 shares by Howard Turner of SunLink Health subject to Rule 16b-3
 
Steven Baileys over two weeks ago
Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3
 
Howard Turner over two months ago
Acquisition by Howard Turner of 1000 shares of SunLink Health at 0.968 subject to Rule 16b-3
 
Steven Baileys over two months ago
Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3
 
Christopher Mills over three months ago
Disposition of 221326 shares by Christopher Mills of SunLink Health at 2.3155 subject to Rule 16b-3
 
Gene Burleson over three months ago
Acquisition by Gene Burleson of 3000 shares of SunLink Health at 0.71 subject to Rule 16b-3
 
Steven Baileys over three months ago
Disposition of 10000 shares by Steven Baileys of SunLink Health at 1.67 subject to Rule 16b-3
 
Christopher Mills over three months ago
Disposition of 44308 shares by Christopher Mills of SunLink Health at 2.3318 subject to Rule 16b-3
 
Mark Stockslager over three months ago
Acquisition by Mark Stockslager of 30000 shares of SunLink Health at 1.22 subject to Rule 16b-3
 
Gene Burleson over three months ago
Disposition of 3000 shares by Gene Burleson of SunLink Health at 0.71 subject to Rule 16b-3
 
Gene Burleson over six months ago
Acquisition by Gene Burleson of 10000 shares of SunLink Health at 1.38 subject to Rule 16b-3
 
Mark Stockslager over six months ago
Disposition of 30000 shares by Mark Stockslager of SunLink Health subject to Rule 16b-3

SunLink Health's Outstanding Corporate Bonds

SunLink Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. SunLink Health Systems uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most SunLink bonds can be classified according to their maturity, which is the date when SunLink Health Systems has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand SunLink Health's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing SunLink Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider SunLink Health's intraday indicators

SunLink Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of SunLink Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
SunLink Health time-series forecasting models is one of many SunLink Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary SunLink Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

SunLink Stock media impact

Far too much social signal, news, headlines, and media speculation about SunLink Health that are available to investors today. That information is available publicly through SunLink media outlets and privately through word of mouth or via SunLink internal channels. However, regardless of the origin, that massive amount of SunLink data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of SunLink Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of SunLink Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to SunLink Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive SunLink Health alpha.

SunLink Health Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards SunLink Health can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

SunLink Health Corporate Directors

C FordIndependent DirectorProfile
Gene BurlesonIndependent DirectorProfile
Karen BrennerIndependent DirectorProfile
Howard TurnerIndependent DirectorProfile

Additional Tools for SunLink Stock Analysis

When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.